| Title | Concord Biotech eyes domestic, other markets to mitigate US tariff threats |
|---|
| URL | https://informistmedia.com/EquityWire/36165/Concord-Biotech-Concord-Biotech-eyes-domestic-other-markets-to-mitigate-US-tariff-threats |
|---|
| Category | Media News --> Media |
|---|
| Meta Keywords | Concord Biotech, biopharma, US tariff |
|---|
| Meta Description | Ahmedabad-based biopharma company Concord Biotech Ltd. is gradually moderating its reliance on exports to the US and exploring newer markets to grow sales amid potential tariff risks, a senior company official said. |
|---|
| Owner | ankita shinde |
|---|
| Description |
|---|
| Ahmedabad-based biopharma company Concord Biotech Ltd. is gradually moderating its reliance on exports to the US and exploring newer markets to grow sales amid potential tariff risks, a senior company official said. While the pharmaceutical industry has remained relatively safe from the impact of tariffs imposed by the US on Indian goods, Concord Biotech is preparing itself to balance its global exposure and face any future disruptions due to tariff imposition, the official said on condition of anonymity. |
